Dr. Dimitra Chalkia is the Vice President of Computational Modeling at Athos Therapeutics Inc. She is overseeing all the bioinformatic and machine learning efforts related to Athos drug development programs and with the identification of the central regulators (hubs) involved in the pathogenesis of different autoimmune diseases, including ulcerative colitis and Crohn’s Disease. Prior joining Athos, Dr. Chalkia was the Director of the Computational Biology Program at the UCLA Center for Systems Biomedicine, where she set up and oversaw analytical pipelines for medical genomics, transcriptomics, and metabolomics. In this role, she was responsible for data mining, analyses, and information synthesis related to cancer, inflammatory bowel diseases, Clostridium difficile infection, antibiotic resistance, and neuroimmune-microbial interactions. Before joining UCLA, she was a Research Associate at Children’s Hospital at University of Pennsylvania. She received her Bachelor and Master of Science degrees in Biology Departments of Aristotle University and University of Crete, respectively and also obtained her Ph.D. on Molecular Evolutionary Genetics at. Penn State University.